Horizon Investments’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$141K Buy
2,690
+167
+7% +$10K ﹤0.01% 1037
2025
Q4
$148K Buy
2,523
+59
+2% +$3.58K ﹤0.01% 1011
2025
Q3
$137K Sell
2,464
-100
-4% -$5.36K ﹤0.01% 952
2025
Q2
$132K Buy
2,564
+239
+10% +$12K ﹤0.01% 924
2025
Q1
$136K Buy
2,325
+169
+8% +$11.5K ﹤0.01% 594
2024
Q4
$155K Buy
2,156
+18
+0.8% +$1.32K ﹤0.01% 575
2024
Q3
$171K Sell
2,138
-706
-25% -$53.1K ﹤0.01% 567
2024
Q2
$204K Buy
2,844
+347
+14% +$25.5K 0.01% 541
2024
Q1
$176K Sell
2,497
-44
-2% -$3.15K ﹤0.01% 564
2023
Q4
$196K Buy
2,541
+141
+6% +$9.29K 0.01% 529
2023
Q3
$163K Buy
2,400
+29
+1% +$2.29K 0.01% 551
2023
Q2
$194K Buy
2,371
+223
+10% +$17.9K 0.01% 522
2023
Q1
$159K Sell
2,148
-680
-24% -$52.4K ﹤0.01% 559
2022
Q4
$234K Buy
+2,828
New +$225K 0.01% 502

Other funds holding TECH

Horizon Investments's TECH Position: Q1 2026 in Review

Horizon Investments increased its Bio-Techne (TECH) stake by 6.6% in Q1 2026, buying an estimated $10K and bringing the position to 2,690 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Horizon Investments first reported a position in TECH in Q4 2022 and has held it in 14 quarters since. The position peaked at $234K in Q4 2022. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Horizon Investments held 2,690 shares of Bio-Techne worth $141K as of Q1 2026.
  • Horizon Investments bought 167 Bio-Techne shares in Q1 2026, an estimated $10K.
  • Bio-Techne made up ﹤0.01% of Horizon Investments's portfolio in Q1 2026, its #1037 holding.
  • Horizon Investments first reported a position in Bio-Techne in Q4 2022 and has held it in 14 quarters since.
  • Horizon Investments's Bio-Techne position peaked at $234K in Q4 2022.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.